Latest 8-K filings

Inhibikase Therapeutics, Inc. has dismissed CohnReznick LLP as its independent auditor and appointed Deloitte & Touche LLP.

Sky Harbour Group Corporation successfully closed a registered direct offering of 1,000,000 shares of Class A common stock, raising $10 million in gross proceeds.

Mercury General Corporation announced the passing of its founder and longtime Chairman, George Joseph, and the immediate appointment of CEO Gabriel Tirador as Chairman, ensuring leadership continuity.

Vireo Growth Inc. has successfully acquired C21 Investments Inc., expanding its Nevada footprint with three new dispensaries and significant cultivation capacity.

CSB Bancorp, Inc. announced its Board of Directors has declared a third quarter cash dividend of $0.45 per share, a $0.02 increase from the previous quarter and a $0.04 increase year-over-year.

Copper Property CTL Pass Through Trust has filed a lawsuit against Anton Melchionda and Onyx Partners Ltd., LLC, alleging fraud and deceptive conduct in a failed $947 million real estate transaction.

Tenon Medical, Inc. filed an amendment to its Form 8-K to correct details regarding its convertible promissory notes, including the aggregate principal amount and floor price.

Tevogen Inc. announced the approval of significant amendments to its 2024 Omnibus Incentive Plan and its Certificate of Incorporation, enabling greater flexibility in stock issuance and shareholder actions.

Black Hawk Acquisition Corp. has entered into a material definitive agreement for a convertible promissory note of up to $300,000 with its sponsor, Black Hawk Management LLC.

Revolution Medicines announced FDA approval for RASONQUE (daraxonrasib) for metastatic pancreatic adenocarcinoma, a significant step for the company and patients.

Leggett & Platt, Inc. has been acquired by Somnigroup International Inc. through a merger, resulting in the delisting of its common stock from the NYSE.

Worksport Ltd. announced record July product orders of approximately $2.52 million, contributing to a $30 million Annualized Revenue Rate and sustained month-over-month sales growth.

Somnigroup International Inc. has finalized its acquisition of Leggett & Platt, Inc., strengthening its global platform and vertical integration.

FDCTech, Inc. announced the conversion of all Series B Preferred Stock into common stock, a 1-for-100 reverse stock split, and an increase in authorized shares.

American National Group Inc. released its second quarter 2026 financial supplement, reporting a substantial year-over-year increase in net income.

Inflection Point Acquisition Corp. VII, formerly Columbus Circle Capital Corp II, announced its official name change and confirmed new trading symbols effective August 27, 2026.

Saratoga Investment Corp. has entered into an Eighteenth Supplemental Indenture to facilitate the issuance of $85 million in 8.00% Notes due 2031, with net proceeds intended for the redemption of existing 6.00% notes.

Interpace Biosciences, Inc. filed an amendment to its Form 8-K to officially disclose the adoption of its 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan, following stockholder approval.

Spruce Power Holding Corporation's stockholders have overwhelmingly approved the election of two Class C directors, the redomiciliation from Delaware to Texas, and other key proposals at the reconvened 2026 Annual Meeting.

Summit Therapeutics' partner, Akeso, Inc., announced positive topline results from the Phase III HARMONi-GI1 study evaluating ivonescimab plus chemotherapy for advanced biliary tract cancer, meeting primary and key secondary endpoints.

Nomadar Corp. announced a significant corporate reorganization plan that aims to position the company as the parent of Spanish football club Cdiz CF, involving a reverse financial partial spin-off.

Abundia Global Impact Group, Inc. announced its Board of Directors has authorized a stock repurchase program of up to $5 million, effective August 25, 2026.

Gevo, Inc. announces executive leadership realignments, including the appointment of Greg Hanselman as COO, to drive commercial execution, North Dakota expansion, and overall growth strategy.

Gyre Therapeutics, Inc. has released an updated corporate presentation detailing advancements in its protein degrader and Degrader Antibody-Conjugate (DAC) platforms, alongside commercial updates for its fibrosis franchise.

Duos Technologies Group, Inc. announced the appointment of Christopher J. DeAlmeida as its new Chief Financial Officer, effective August 24, 2026.

Ascent Industries Co. details its strategic transformation, focusing on specialty chemicals, and highlights the accretive acquisition of Midwest Graphic Sales & Sigma Coatings.

Waste Management, Inc. announced the planned retirement of CEO Jim Fish, effective January 4, 2027, with President John Morris appointed as his successor.

Celcuity Inc. announced the submission of a supplemental New Drug Application (sNDA) to the FDA for REVTORPYK (gedatolisib) for a specific subset of advanced breast cancer patients.

Borealis Foods Inc. reports a 110% year-over-year increase in preliminary revenue from its U.S. K12 school foodservice channel, alongside significant expansion to over 20,000 schools.

Micron Technology has appointed Manish Bhatia as President and Chief Operating Officer and Dr. Scott DeBoer as President and Chief Technology and Products Officer to drive innovation and growth.